The National Association of Statutory Health Insurance Funds (GKV-Spitzenverband) is the central body representing all statutory health insurance funds in Germany. Established to unify and coordinate the interests of its member funds, GKV-Spitzenverband plays a pivotal role in shaping healthcare policies, negotiating reimbursement prices, and ensuring the provision of comprehensive healthcare services to insured individuals.
Core Functions of GKV-Spitzenverband
GKV-Spitzenverband’s primary responsibilities include:- Negotiation of Reimbursement Prices: Collaborating with pharmaceutical companies to determine reimbursement prices, also called refund amounts, for new medications, following benefit assessments by the Federal Joint Committee (G-BA).
- Development of Care Contracts: Establishing nationwide contracts with healthcare providers to ensure standardized and quality care for insured individuals.
- Policy Advocacy: Representing the interests of statutory health insurance funds in discussions with policymakers to influence healthcare legislation and reforms.
Leadership and Key Contacts
As of January 2025, GKV-Spitzenverband is led by Chairperson Dr. Doris Pfeiffer, who oversees the organization’s strategic initiatives and operations.Contact Details for GKV-Spitzenverband
Website: https://www.gkv-spitzenverband.de/ Address: GKV-Spitzenverband Reinhardtstraße 28 10117 Berlin, GermanyChallenges in Working with GKV-Spitzenverband
Engaging with GKV-Spitzenverband involves:- Understanding Negotiation Processes: Familiarity with the procedures and criteria used by GKV-Spitzenverband in price negotiations is crucial for successful market access. This includes relevant laws, the framework agreement according to § 130b Abs. 9 SGB V (Rahmenvereinbarung nach § 130b Abs. 9 SGB V) and relevant case law of the arbitration board and its rulings.
- Timely and Accurate Submissions: Ensuring that all necessary documentation is complete and submitted promptly to facilitate the negotiation process.
- Stakeholder Collaboration: Working effectively with various healthcare stakeholders in Germany to align with GKV-Spitzenverband’s guidelines and agreements.
Opportunities / Solutions with Justin Stindt Consultants
Justin Stindt GKV-Spitzenverband expertise ensures:- Expert Consultant GKV-Spitzenverband Submissions: Creating high-quality submissions for pricing negotiations and policy engagements.
- Market Access GKV-Spitzenverband Strategies: Proven methods for optimizing pricing outcomes.
- Specialist GKV-Spitzenverband Processes: In-depth knowledge of German health insurance regulations and laws to accelerate approvals. Justin Stindt Consultants also partners with specialized healthcare lawyers who support negotiating contracts with GKV-Spitzenverband.
Case Studies
A Pharmaceutical Company’s Success with GKV-Spitzenverband
Challenge:
A pharmaceutical company sought our assistance to negotiate a favorable reimbursement price for a novel therapy in Germany.
Solution:
We guided them in preparing a comprehensive negotiation strategy and mock negotiations that addressed GKV-Spitzenverband’s evaluation criteria.
Outcome:
Our strategic approach led to a positive outcome, enabling the therapy’s sustainable pricing.
.
Need support with GKV market access? Justin Stindt Consultants has the expertise to help you succeed.
Contact us today to discuss your market access strategy and ensure your success with GKV.
Other Key Institutions in Market Access
Global Institutions
- World Health Organization (WHO)
- International Society for Pharmacoeconomics and Outcomes Research (ISPOR)
United States
- Centers for Medicare & Medicaid Services (CMS)
- Academy of Managed Care Pharmacy (AMCP)
- Institute for Clinical and Economic Review (ICER)
France
Germany
- Gemeinsamer Bundesausschuss (G-BA)
- Institute for Quality and Efficiency in Health Care (IQWiG)
- GKV Spitzenverband
United-Kingdom
- National Institute for Health and Care Excellence (NICE)
- Scottish Medicines Consortium (SMC)
- All Wales Medicines Strategy Group (AWMSG)
- National Health Service (NHS)
Italy
Spain
- Spanish Agency of Medicines and Medical Devices (AEMPS)
- Dirección General de Cartera Común de Servicios del Sistema Nacional de Salud y Farmacia (DGCF)
- Interministerial Commission on Medicine Prices (CIPM)